Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan versus placebo before tricuspid valve surgery in patients with right ventricular dysfunction
2020-005600-19Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Tricuspid insufficiency (TR) comparing ZIMINO with Placebo (2 arms). Started May 2021; status: active.
02
Drugs
levosimendan
03
Conditions
Tricuspid insufficiency (TR)
Beyond the preview
Go deeper on 2020-005600-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005600-19.